These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 19998551)

  • 1. Molecular advances in early breast cancer. Breast cancers are as diverse as the women who have them. Now experts are using gene-based information to tailor treatment.
    Harv Womens Health Watch; 2009 Oct; 17(2):1-3. PubMed ID: 19998551
    [No Abstract]   [Full Text] [Related]  

  • 2. Toward optimal health: the experts discuss advances in breast cancer management.
    Godfrey J
    J Womens Health (Larchmt); 2004; 13(1):25-31. PubMed ID: 15006275
    [No Abstract]   [Full Text] [Related]  

  • 3. Ductal carcinoma in situ (DCIS). A highly treatable breast cancer.
    Mayo Clin Womens Healthsource; 2009 Oct; 13(10):1-2. PubMed ID: 19727033
    [No Abstract]   [Full Text] [Related]  

  • 4. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
    Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A
    Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of epidermal growth factor receptor and c-erbB2 during the development of tamoxifen resistance in human breast cancer.
    Newby JC; Johnston SR; Smith IE; Dowsett M
    Clin Cancer Res; 1997 Sep; 3(9):1643-51. PubMed ID: 9815855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple-negative breast cancer.
    Stockmans G; Deraedt K; Wildiers H; Moerman P; Paridaens R
    Curr Opin Oncol; 2008 Nov; 20(6):614-20. PubMed ID: 18841042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour epidermal growth factor receptor, erbB-2 and cathepsin D in node-negative invasive breast cancer: their impact on the selection of patients for systemic adjuvant therapy.
    Tonkin KS; McKay JW; Stitt LW; Tokmakejian S; Haines DS
    Cancer Prev Control; 1999 Apr; 3(2):131-6. PubMed ID: 10474760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy for early-stage breast cancer.
    McArthur HL; Hudis CA
    Hematol Oncol Clin North Am; 2007 Apr; 21(2):207-22. PubMed ID: 17512445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant therapy for breast cancer.
    Atkins CD
    N Engl J Med; 1994 Sep; 331(11):744; author reply 745-6. PubMed ID: 7914676
    [No Abstract]   [Full Text] [Related]  

  • 10. Linkage between EGFR family receptors and nuclear factor kappaB (NF-kappaB) signaling in breast cancer.
    Biswas DK; Iglehart JD
    J Cell Physiol; 2006 Dec; 209(3):645-52. PubMed ID: 17001676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efforts to combine endocrine agents with targeted therapies against epidermal growth factor receptor/human epidermal growth factor receptor 2 and mammalian target of rapamycin in breast cancer.
    Johnston SR
    Clin Cancer Res; 2006 Feb; 12(3 Pt 2):1061s-1068s. PubMed ID: 16467125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of prognostic profiling in breast cancer.
    Pusztai L
    Oncologist; 2008 Apr; 13(4):350-60. PubMed ID: 18448548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HER2 expression and efficacy of preoperative paclitaxel/FAC chemotherapy in breast cancer.
    Andre F; Mazouni C; Liedtke C; Kau SW; Frye D; Green M; Gonzalez-Angulo AM; Symmans WF; Hortobagyi GN; Pusztai L
    Breast Cancer Res Treat; 2008 Mar; 108(2):183-90. PubMed ID: 17468948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Early-stage breast cancer - strategies for adjuvant systemic therapy].
    Görner M; Just M; Gerull S
    Handchir Mikrochir Plast Chir; 2008 Aug; 40(4):230-8. PubMed ID: 18716990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding ductal carcinoma in situ. Most women diagnosed with this noninvasive breast cancer are alive 10 years later, and better treatments are emerging.
    Harv Womens Health Watch; 2008 Oct; 16(2):1-3. PubMed ID: 19051424
    [No Abstract]   [Full Text] [Related]  

  • 16. Estrogen receptor-negative and human epidermal growth factor receptor 2-negative breast cancer tissue have the highest Ki-67 labeling index and EGFR expression: gene amplification does not contribute to EGFR expression.
    Umemura S; Takekoshi S; Suzuki Y; Saitoh Y; Tokuda Y; Osamura RY
    Oncol Rep; 2005 Aug; 14(2):337-43. PubMed ID: 16012712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Her2/neu overexpression is associated with treatment failure in women with high-risk stage II and stage IIIA breast cancer (>10 involved lymph nodes) treated with high-dose chemotherapy and autologous hematopoietic progenitor cell support following standard-dose adjuvant chemotherapy.
    Bitran JD; Samuels B; Trujillo Y; Klein L; Schroeder L; Martinec J
    Clin Cancer Res; 1996 Sep; 2(9):1509-13. PubMed ID: 9816327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemo-signal therapy, an emerging new approach to modify drug resistance in breast cancer.
    Pusztai L; Esteva FJ; Cristofanilli M; Hung MC; Hortobagyi GN
    Cancer Treat Rev; 1999 Oct; 25(5):271-7. PubMed ID: 10544071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of C-erbB-2/HER-2 in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous blood stem cell support.
    Bewick M; Chadderton T; Conlon M; Lafrenie R; Morris D; Stewart D; Glück S
    Bone Marrow Transplant; 1999 Aug; 24(4):377-84. PubMed ID: 10467326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing paradigms in breast cancer management: introducing molecular genetics into the treatment algorithm.
    Rayhanabad JA; Difronzo LA; Haigh PI; Romero L
    Am Surg; 2008 Oct; 74(10):887-90. PubMed ID: 18942607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.